IE911403A1 - Compositions and method for topical treatment of damaged or¹diseased tissue - Google Patents

Compositions and method for topical treatment of damaged or¹diseased tissue

Info

Publication number
IE911403A1
IE911403A1 IE140391A IE140391A IE911403A1 IE 911403 A1 IE911403 A1 IE 911403A1 IE 140391 A IE140391 A IE 140391A IE 140391 A IE140391 A IE 140391A IE 911403 A1 IE911403 A1 IE 911403A1
Authority
IE
Ireland
Prior art keywords
composition
die
weight
represented
copolymer
Prior art date
Application number
IE140391A
Other languages
English (en)
Original Assignee
Cytrx Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytrx Corp filed Critical Cytrx Corp
Publication of IE911403A1 publication Critical patent/IE911403A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IE140391A 1990-04-26 1991-04-25 Compositions and method for topical treatment of damaged or¹diseased tissue IE911403A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51350990A 1990-04-26 1990-04-26
US68703491A 1991-04-22 1991-04-22

Publications (1)

Publication Number Publication Date
IE911403A1 true IE911403A1 (en) 1991-11-06

Family

ID=27057898

Family Applications (1)

Application Number Title Priority Date Filing Date
IE140391A IE911403A1 (en) 1990-04-26 1991-04-25 Compositions and method for topical treatment of damaged or¹diseased tissue

Country Status (10)

Country Link
EP (1) EP0526578A4 (xx)
JP (1) JPH0776175B2 (xx)
CN (1) CN1058341A (xx)
AU (1) AU647484B2 (xx)
BR (1) BR9106377A (xx)
CA (1) CA2081340A1 (xx)
IE (1) IE911403A1 (xx)
IL (1) IL97976A0 (xx)
PT (1) PT97504A (xx)
WO (1) WO1991016058A1 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
US6153193A (en) * 1993-04-28 2000-11-28 Supratek Pharma Inc. Compositions for targeting biological agents
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
US6093391A (en) * 1992-10-08 2000-07-25 Supratek Pharma, Inc. Peptide copolymer compositions
US6353055B1 (en) 1994-11-18 2002-03-05 Supratek Pharma Inc. Polynucleotide compositions
US6221959B1 (en) 1994-11-18 2001-04-24 Supratek Pharma, Inc. Polynucleotide compositions
CA2232527C (en) * 1995-09-19 2008-09-02 Seikagaku Corporation Anti-inflammatory agent
JP2001187740A (ja) * 2000-01-05 2001-07-10 Seikagaku Kogyo Co Ltd 創傷治療剤
FR2833268B1 (fr) * 2001-12-12 2005-07-08 Fabre Pierre Dermo Cosmetique Nouvelle association contenant un poloxamer et de l'acide chondroitine sulfurique et/ou une glycoproteine et son utilisation
MX2020002288A (es) 2016-08-31 2020-07-14 Oji Holdings Corp Metodo de produccion para xilooligosacarido acido y xilooligosacarido acido.
JP6225321B1 (ja) 2016-08-31 2017-11-08 王子ホールディングス株式会社 ポリ硫酸ペントサンの製造方法
JP6281659B1 (ja) 2017-02-28 2018-02-21 王子ホールディングス株式会社 ポリ硫酸ペントサン、医薬組成物及び抗凝固剤
KR20240023711A (ko) * 2017-05-31 2024-02-22 오지 홀딩스 가부시키가이샤 보습 외용제
MX2020002726A (es) 2017-09-12 2020-07-20 Oji Holdings Corp Polisulfato de pentosan y metodo para producir polisulfato de pentosan.
HUE062342T2 (hu) 2017-12-20 2023-10-28 Oji Holdings Corp Pentozán-poliszulfát, valamint pentozán-poliszulfátot tartalmazó gyógyszerek
CN111228466B (zh) * 2020-02-27 2023-06-27 温州医科大学 治疗糖尿病足的含氧气微泡的水凝胶及其制备方法和用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997458A (en) * 1974-04-12 1976-12-14 Deknatel, Incorporated Method of cleansing contaminated wounds and surgical scrub solutions for same
US4052513A (en) * 1974-12-13 1977-10-04 Plough, Inc. Stable topical anesthetic compositions
IT1212892B (it) * 1983-10-11 1989-11-30 Della Valle Francesco Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica
US4745098A (en) * 1984-02-24 1988-05-17 The Regents Of The University Of California Compositions and method for improving wound healing
US4711780A (en) * 1984-06-11 1987-12-08 Fahim Mostafa S Composition and process for promoting epithelial regeneration
CH662505A5 (it) * 1985-04-30 1987-10-15 Seuref Ag Composizioni farmaceutiche ad azione protettiva vascolare.
JPS61253065A (ja) * 1985-05-02 1986-11-10 片倉チツカリン株式会社 キトサン誘導体およびコラ−ゲンの複合材の医用材料およびその製造法
FR2585575B1 (fr) * 1985-08-01 1989-03-03 Pf Medicament Compositions pharmaceutiques a activite keratolytique sous forme de gel comportant de l'acide salicylique hydro-alcoolique
CA1294546C (en) * 1986-04-23 1992-01-21 John S. Sundsmo Wound healing composition containing collagen
US4760131A (en) * 1986-04-23 1988-07-26 Collagen Corporation Wound-healing composition
US4879109A (en) * 1986-05-15 1989-11-07 Emory University Method for treating burns
US4925678A (en) * 1987-04-01 1990-05-15 Ranney David F Endothelial envelopment drug carriers
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor

Also Published As

Publication number Publication date
JPH05506861A (ja) 1993-10-07
EP0526578A4 (en) 1993-09-22
IL97976A0 (en) 1992-06-21
JPH0776175B2 (ja) 1995-08-16
WO1991016058A1 (en) 1991-10-31
PT97504A (pt) 1992-02-28
EP0526578A1 (en) 1993-02-10
BR9106377A (pt) 1993-04-27
CN1058341A (zh) 1992-02-05
CA2081340A1 (en) 1991-10-27
AU7869291A (en) 1991-11-11
AU647484B2 (en) 1994-03-24

Similar Documents

Publication Publication Date Title
US4725609A (en) Method of promoting healing
IE911403A1 (en) Compositions and method for topical treatment of damaged or¹diseased tissue
US20050214376A1 (en) Hydrogel-containing medical articles and methods of using and making the same
EP2489338B1 (en) Dry wound dressing and drug delivery system
CN103083713A (zh) 一种无菌聚合创面覆盖物敷料
CN101130105A (zh) 聚维酮碘水凝胶创伤敷料及其辐射制备方法
EP3585422B1 (en) Antiseptic composition comprising unithiol and dimethylsulfoxide, use of the composition and method of wound treatment with its use
CN106937941A (zh) 一种医用皮肤伤口消炎凝胶及其制备方法
CN110198721B (zh) 含有聚乙烯吡咯烷酮和二巯基丙磺酸钠的抗菌组合物及其用途
CN106937942A (zh) 一种医用皮肤伤口镇痛凝胶及其制备方法
CN110840894B (zh) 一种复合抗疤痕硅酮喷雾剂及其制备方法
RU2178693C2 (ru) Противовирусное средство для наружного применения на основе гиалуроновой кислоты
CN116407673A (zh) 一种外科液体敷料及其生产工艺
Wang et al. Temporary Skin Substitute from Non-Antigenic Dextran Hydrogel
Bajpai et al. Polymer biomaterials in wound dressing: A review
CA2390841A1 (en) Drug preparations
CN113633818A (zh) 一种多肽抗生素抗菌人工敷料的研制
CN113143844A (zh) 一种用于治疗痤疮的聚合物微针贴片及其制备方法
KR100483227B1 (ko) 푸시딘산외용분사제조성물
CN114732941A (zh) 一种清洁抑菌凝胶的制备方法